Company / Operating Margin
IGC Pharma, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-585.8%
FY2025
5-year range
-3886.2% / -168.6%
FY2021-FY2025
Trend
+53.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -3886.2% in FY2023 to -45.6% in FY2017.
Based on SEC 10-K filings.
-585.8% in FY2025 with a 5-year CAGR of -495.1%.
Improved from -3886.2% to -585.8% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +385.7pp
- 5-Year Change
- -495.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 53.9% year-over-year.
- Peak operating margin was recorded in FY2017.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -585.8% | +53.9% |
| FY2024 | -1270.1% | +67.3% |
| FY2023 | -3886.2% | -300.0% |
| FY2022 | -971.5% | -476.3% |
| FY2021 | -168.6% | -85.8% |
| FY2020 | -90.8% | -11.2% |
| FY2019 | -81.6% | +77.0% |
| FY2018 | -354.0% | -675.6% |
| FY2017 | -45.6% | +19.3% |
| FY2016 | -56.5% | +49.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026